Texas · A9539

Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries in Texas

Texas Medicare Avg
$135.14
92% above national avg
National Medicare Avg
$70.50
All states combined
Billed Charge (TX)
$459.87
What providers submit
Est. Commercial (TX)
$390.13
National avg: $198.68
Est. Cash / Self-Pay (TX)
$253.68
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

38
Services in TX
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Excel Diagnostics Ltd $135.94 30

Texas Pricing in Context

In Texas, CPT code A9539 (Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries) carries an average Medicare payment of $135.14 — 92% above the national benchmark of $70.50. 2 providers across the state submitted claims for this procedure in 2023, performing 38 total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $459.87, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Texas lands near $390.13, with self-pay cash prices typically around $253.68. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries cost in Texas?

The average Medicare payment for Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries in Texas is $135.14, which is 92% above the national average of $70.50. Providers in TX typically bill $459.87 for this procedure.

What does Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries cost with insurance in Texas?

With commercial insurance in Texas, Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries costs an estimated $390.13. Without insurance, the estimated cash price is $253.68. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries in Texas?

2 providers in Texas billed Medicare for Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries in 2023, performing 38 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries cheaper in Texas than the national average?

No — Technetium Tc-99m Pentetate, Diagnostic, Per Study Dose, Up To 25 Millicuries costs 92% above the national average in Texas. The state average Medicare payment is $135.14 compared to $70.50 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial